Skip to Main Content

Paper Details

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Nature
452
2020
-, ACE2, BALB, COVID-19, COVID-196, Foxj1, Hfh4, Hfh4 (also known as Foxj1) promoter, IFN-1a, SARS, SARS-CoV, SARS-CoV-, SARS-CoV-2, SARS-CoV-2 disease, SARS-CoV-2 spike protein, angiotensin-, angiotensin-converting enzyme 2, cells, coronavirus disease 2019, human, human ACE2, humans, interferon-1a, mice, mouse, mouse ACE2, pegylated IFN-1a, primary human airway epithelial cells, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2, viral spike protein
Author NameAffiliation
Sarah R LeistUniversity of North Carolina at Chapel Hill
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Stephanie A MontgomeryUniversity of North Carolina
Ande WestUniversity of North Carolina at Chapel Hill
Boyd L YountUniversity of North Carolina at Chapel Hill
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina
  • 1 - 13

Datasets

Release 1.2